1 Top AI Stock That Soared In 2025 I Would Take My Profits on Before 2026

Palantir reported accelerating top-line momentum with Q3 revenue up 63% year-over-year to roughly $1.2 billion (U.S. revenue +77%; U.S. commercial revenue +121% to $397 million) and raised full-year 2025 revenue guidance to $4.396–4.400 billion from prior $4.142–4.150 billion. The stock has rallied ~150% YTD on AI-driven optimism, but the market now prices in aggressive growth (roughly 126x sales, trailing P/E ~448, forward P/E ~192), creating valuation risk that the author says justifies trimming positions rather than adding exposure.

Analysis

Market structure: Palantir (PLTR) is a direct beneficiary of AI spending — customers (DoD, large enterprise analytics buyers) and infrastructure vendors (NVDA, MSFT, AMZN) gain as adoption accelerates. The 150% YTD run has concentrated risk: PLTR's 126x sales and 192x forward P/E price in future operating leverage, compressing pricing power for smaller pure‑play analytics vendors while increasing capital flow into AI infrastructure names.

Risk assessment: Key tail risks are loss/renegotiation of large government contracts, an AI-hype derating of multiples, or a miss on margin expansion; any one could trigger 30–60% downside within weeks. Immediate horizon (days): elevated IV and two-way flows; short-term (30–90 days): earnings/guidance and contract announcements; long-term: execution on AIP and commercial diversification (12–36 months).

Trade implications: Near-term hedging and partial profit-taking are rational — volatility will remain elevated and a 20–40% drawdown is plausible if sentiment flips. Use collars/put spreads to preserve gains in taxable accounts, redeploy proceeds into AI infrastructure (NVDA, MSFT) or diversified ETFs; prefer option-defined-risk structures to avoid forced taxable events.

Contrarian angles: Consensus discounts are binary: if AIP adoption compounds revenue >30% CAGR next 3 years, current multiples could be justified — but market isn’t paying for “very good” growth. Mispricings exist in options: IV skew implies cheap downside protection via put spreads vs expensive outright puts; an overbaked long consensus also raises squeeze risk if short interest grows.

Key Decisions for Investors

• Trim 25–50% of existing PLTR holdings within 5 trading days to reduce concentration; target residual PLTR weight of 1–2% of portfolio (or max 50% of original position) to lock gains while preserving upside optionality.
• In taxable accounts, replace realized-sale risk with a 3‑month collar on remaining PLTR: buy 1x 10% OTM put and sell 1x 30% OTM call (size to cover remaining shares); if collar costs >1.5% of position, prefer a 3‑month 15/30 put spread instead.
• Establish a relative-value pair trade: go long NVDA (0.5–1% portfolio) and short PLTR (dollar-neutral 0.5–1%) or hedge PLTR exposure with 3‑month 10–15% OTM put spreads sized to cover 30–40% of position; re-evaluate after 90 days or post next earnings.
• Sell 3–6 month covered calls on up to 50% of remaining PLTR shares at ~30% OTM to harvest premium; set buyback rule if premium declines >50% or PLTR gaps down >25%.
• Monitor two catalysts over next 30–60 days: (1) Q4 revenue/guidance vs raised FY25 guide (add if next-quarter guidance exceeds consensus by ≥5%), and (2) major government contract awards or cancellations (reduce/add if government revenue share moves >±10 percentage points).